KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Adaptive Biotechnologies (ADPT) Return on Assets (2019 - 2025)

Adaptive Biotechnologies' Return on Assets history spans 7 years, with the latest figure at 0.12% for Q4 2025.

  • For Q4 2025, Return on Assets rose 18.0% year-over-year to 0.12%; the TTM value through Dec 2025 reached 0.12%, up 18.0%, while the annual FY2025 figure was 0.11%, 15.0% up from the prior year.
  • Return on Assets for Q4 2025 was 0.12% at Adaptive Biotechnologies, up from 0.16% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.12% in Q4 2025 and bottomed at 0.35% in Q2 2024.
  • The 5-year median for Return on Assets is 0.25% (2022), against an average of 0.24%.
  • The largest annual shift saw Return on Assets dropped -12bps in 2022 before it rose 18bps in 2025.
  • A 5-year view of Return on Assets shows it stood at 0.22% in 2021, then decreased by -4bps to 0.23% in 2022, then crashed by -45bps to 0.33% in 2023, then rose by 11bps to 0.29% in 2024, then soared by 60bps to 0.12% in 2025.
  • Per Business Quant, the three most recent readings for ADPT's Return on Assets are 0.12% (Q4 2025), 0.16% (Q3 2025), and 0.24% (Q2 2025).